Affiliation:
1. Northern State Medical University
2. Northern State Medical University; Arkhangelsk Regional Clinical Hospital
Abstract
Aim: to assess the dynamic changes of humoral immune responses against the S-protein of SARS-CoV-2 and vitamin D level in healthcare workers providing care to COVID-19 patients.Methods. Repeated cross-sectional studies were conducted with an interval of 6 months (May-December 2021) including 170 healthcare workers of infectious settings. An enzyme linked immunosorbent assay was used for the quantitative detection of immunoglobulins G to SARS-CoV-2 and the vitamin D level in the blood serum.Results. In 1.5 years after the start of the pandemic, 91.2% healthcare workers were seropositive to SARS-Co-V-2. In December 2021, this proportion became 98.8%, and the percentage of individuals with high antibodies level (>150 BAU / ml) raised from 49.4% to 77%. Increase in antibodies level induced by vaccination against SARS-CoV-2 was significantly higher in those who have had prior COVID-19 (1031 BAU/мл) compared to those previously vaccinated (367 BAU/ml). The vitamin D level was lower than reference values in 71.2% of health workers and did not correlate with the concentration of antibodies to SARS-Co-V-2.Conclusion. SARS-Co-V-2 seroprevalence among healthcare workers reached almost 100% by the end of the second year of the pandemic. A greater increase in antibodies level after vaccination was observed in healthcare workers previously infected with SARS-Co-V-2 due to formation of hybrid immunity. We did not reveal the association between the vitamin D level and the humoral immune response to SARS-Co-V-2.
Reference32 articles.
1. VOZ. Protokol populjacionnogo stratificirovannogo po vozrastu serojepidemiologicheskogo issledovanija infekcii COVID-19 u cheloveka. Versija 2.0.2020. URL: https://apps.who.int/iris/bitstream/handle/10665/332188/WHO-2019-nCoV-Seroepidemiology-2020.2-rus.pdf (дата обращения: 8.02.2023)
2. Hossain, A. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis / A. Hossain, S.M. Nasrullah, Z. Tasnim [et. al.]. – DOI: 10.1016/j.eclinm.2021.100770. – Текст: электронный / / EClinicalMedicine. -2021. URL: https://pubmed.ncbi.nlm.nih.gov/33718853 (дата обращения: 8.02.2023)
3. Novikova, E.A. Retrospektiva mezhdunarodnyh serologicheskih issledovanij po formirovaniju i dinamike gumoral’nogo immunnogo otveta k SARS-CoV-2: ot 2020 k 2021/ E.A. Novikova, A.G. Petrova, E.V. Moskaleva [i dr.]. – DOI: 10.3390/vaccines10122168. – Текст: электронный / / Acta biomedica scientifica. – 2021. – №6 (2). – S. 47-57. URL: https://www.mdpi.com/journal/vaccines (дата обращения: 8.02.2023)
4. Popova, A.Ju. Seroprevalentnost’ k virusu SARS-CoV-2 sredi medicinskih rabotnikov g. Moskvy v aprele–dekabre 2020 goda / A.Ju. Popova, E.B. Ezhlova, A.A. Mel’nikova [i dr.]. – DOI: 10.20953/1729-9225-2021-3-5-13. – Текст: электронный / / Infekcionnye bolezni. – 2021. – №19 (3). – S. 5-13. URL: https://www.elibrary.ru/item.asp?id=47207379 (дата обращения: 8.02.2023)
5. Bloh, A. I. Ocenka urovnja serokonversii k SARS-CoV-2 u personala mediko-sanitarnoj chasti / A.I. Bloh, I.I. Panjushkina, P.O. Pahtusova [i dr.]. – DOI: 10.31631/2073-3046-2021-20-5-32-38. – Текст: электронный / / Jepidemiologija i Vakcinoprofilaktika. – 2021. – № 20(5). – S. 32-38. URL: https://www.epidemvac.ru/jour/article/view/1361/780 (дата обращения: 8.02.2023)